ArriVent BioPharma Inc.

AVBP | NASDAQ

Price Alert Chart Builder DCF Calculator

$29.74

+$0.84 (+2.91%)

At close: Sep 21, 2026, 4:00 PM ET

$29.51

-$0.23 (-0.77%)

Pre-market: Sep 22, 2026, 7:31 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021
Cash & Equivalents	45.54M	74.29M	150.39M	163.37M	37.28M
Short-Term Investments	267.28M	144.57M	n/a	n/a	n/a
Long-Term Investments	n/a	47.68M	n/a	n/a	n/a
Other Long-Term Assets	259K	126K	2.84M	72K	87K
Receivables	60K	500K	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a
Other Current Assets	19.83M	7.21M	9.21M	18.92M	5.64M
Total Current Assets	332.9M	226.98M	159.97M	182.62M	42.95M
Property-Plant & Equipment	13K	154K	291K	139K	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	272K	47.96M	3.13M	211K	87K
Total Assets	333.17M	274.94M	163.1M	182.83M	43.04M
Account Payables	5.93M	3.78M	4.53M	3.09M	293K
Deferred Revenue	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	6.55M	4.16M	n/a	n/a	612K
Total Current Liabilities	25.95M	17.27M	11.62M	8.36M	1.82M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	n/a	14K	177K	11K	n/a
Total Liabilities	25.95M	17.29M	11.8M	8.37M	1.82M
Total Debt	14K	176K	317K	139K	n/a
Book Value	307.22M	257.65M	151.3M	174.46M	41.22M
Book Value Per Share	7.99	8.19	4.73	5.21	32.30
Common Stock	4K	3K	n/a	n/a	n/a
Retained Earnings	-404.64M	-238.33M	-157.85M	-88.51M	-51.61M
Comprehensive Income	14K	-211K	n/a	n/a	-2K
Shareholders Equity	307.22M	257.65M	151.3M	174.46M	41.22M
Total Investments	267.28M	192.25M	n/a	n/a	n/a